Neuphoria Therapeutics Inc. (NEUP) Insider Trading

Name: Neuphoria Therapeutics Inc. (NEUP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jan 21, 2026): David Ian Wilson (Director): Grant/Award of 8,537 shares.

Get alerted when insiders trade NEUP

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta